Literature DB >> 22748596

Preoperative hyponatremia predicts outcomes after cardiac surgery.

Juan A Crestanello1, Gary Phillips, Michael S Firstenberg, Chittoor Sai-Sudhakar, John Sirak, Robert Higgins, William T Abraham.   

Abstract

OBJECTIVE: To study the effect of preoperative hyponatremia (Na <135 mEq/L) on outcomes after cardiac surgery.
METHODS: From 2002 to 2008, 4370 patients had cardiac surgery at our institution (CABG in 2238, valve in 597, CABG valve in 537, other in 998). The institution electronic medical records, STS database, and Social Security death index data were analyzed. The association of hyponatremia with mortality, hospital length of stay (LOS), and complications was analyzed using regression analysis.
RESULTS: Prevalence of hyponatremia was 21%. Patients with preoperative hyponatremia had lower left ventricular ejection fraction (39% ± 17% versus 46% ± 14%, P < 0.001) and glomerular filtration rate (69 ± 32 mg/min/1.73 m(2)versus 74 ± 27 mg/min/1.73 m(2), P < 0.001) and higher median EuroSCORE (19% versus 9%, P < 0.001), NYHA class 3-4 (77% versus 65%, P < 0.001), prevalence of chronic obstructive pulmonary disease (25% versus 18%, P < 0.001), and arteriopathy (20% versus 13%, P < 0.001). Hyponatremia was associated with increased early mortality (9% versus 4%, P < 0.001), late mortality (24% versus 16%, P < 0.001), and LOS (13 versus 8 d, P < 0.001). Mortality increased with the severity of hyponatremia. After adjusting for baseline and operative variables, hyponatremia was associated with increased hazard of mortality (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.14-1.52, P < 0.001), risk of early mortality (odds ratio [OR] 1.52, 95% CI 1.09-2.12, P < 0.001), late mortality (HR 1.37, 95% CI 1.16-1.62, P < 0.001), LOS (multiplier 1.26, 95% CI 1.15-1.39, P < 0.001), operative complications (OR 1.30, 95% CI 1.00-1.69, P = 0.051), and dialysis (OR 1.64, 95% CI 1.11-2.44, P = 0.013).
CONCLUSIONS: Preoperative hyponatremia is common, especially in high-risk patients. It is an independent risk factor for mortality, prolonged hospitalization, and complications after cardiac surgery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22748596     DOI: 10.1016/j.jss.2012.06.004

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

2.  Preoperative hyponatremia predicts complications in older patients undergoing digestive tract surgery: a propensity score matching analysis.

Authors:  Chun-Qing Li; Chen Zhang; Fan Yu; Hao Kong; Chun-Mei Deng
Journal:  Eur Geriatr Med       Date:  2021-09-23       Impact factor: 3.269

3.  Predicting the risk of death following coronary artery bypass graft made simple: a retrospective study using the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Paul J Chung; Timothy I Carter; Joshua H Burack; Sophia Tam; Antonio Alfonso; Gainosuke Sugiyama
Journal:  J Cardiothorac Surg       Date:  2015-04-29       Impact factor: 1.637

4.  Severe hyponatraemia in a patient with a large left atrial myxoma: a case report.

Authors:  Srushti Bhat; Wael I Awad
Journal:  Eur Heart J Case Rep       Date:  2022-03-15

Review 5.  Hyponatremia-A New Diagnostic Marker for Complicated Acute Appendicitis in Children: A Systematic Review and Meta-Analysis.

Authors:  Sachit Anand; Nellai Krishnan; Jana Ròs Birley; Goran Tintor; Minu Bajpai; Zenon Pogorelić
Journal:  Children (Basel)       Date:  2022-07-18

6.  Does Hyponatremia Affect the Short-Term Outcomes of Colorectal Cancer Surgery: A Propensity Score Matching Analysis.

Authors:  Xiao-Yu Liu; Bin Zhang; Bing Kang; Chao Yuan; Zi-Wei Li; Hua Zhang; Zheng-Qiang Wei; Dong Peng
Journal:  Dis Markers       Date:  2022-09-16       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.